Technology

AddToAny

Google+ Facebook Twitter Twitter

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.

Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”

horiba.com/uk/medical

Related Articles

Blood signature could improve early TB diagnosis

A gene signature in the bloodstream could reveal whether someone is going to develop active tuberculosis (TB) months before any symptoms begin.

Exercising on Treadmill iStock

"Exercise makes the blood of obese people healthier"

Exercise can reduce inflammation in obese people by changing the characteristics of their blood, according to new research.

Genetic atlas of proteins

An international team of researchers led by scientists at the University of Cambridge has created the first detailed genetic map of human proteins.

Curing sickle cell disease

Doctors at the University of Illinois Hospital have cured seven adult patients of sickle cell disease.

Top